Summary
The COVID-19 pandemic has boosted the credibility of traditional Chinese medicine (TCM) ingredients, some of which have gained approval as a conjunct therapy for the virus.
Shifting health perceptions and advice stemming from COVID-19 will bring about wider acceptance of TCM-based formulations.
Scope
Reasons to Buy
The COVID-19 pandemic has boosted the credibility of traditional Chinese medicine (TCM) ingredients, some of which have gained approval as a conjunct therapy for the virus.
Shifting health perceptions and advice stemming from COVID-19 will bring about wider acceptance of TCM-based formulations.
Scope
- The desire for alternative therapies to improve health continues to offer scope for TCM herbs and ingredients.
- Over the years TCM herbs and ingredients have gradually gained recognition around the world.
- The COVID-19 pandemic propelled TCM into the spotlight as China relied on it as a conjunct therapy amid the uncertainties and limited knowledge of the virus’ behavior.
- Studies are underway to comprehend the efficacy of TCM ingredients in clinical evaluations.
- The COVID-19 pandemic has boosted opportunities for "natural" aspects in food and drinks.
Reasons to Buy
- Understand the relevant consumer trends and attitudes that drive and support innovation success so you can tap into what is really impacting the industry.
- Gain a broader appreciation of the fast-moving consumer goods industry by gaining insights from both within and outside of your sector.
- Access valuable strategic take-outs to help direct future decision-making and inform new product development.
Table of Contents
- What?
- Why?
- Take Outs
- Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- RITAMIX
- POLA Industries
- WEI Beauty
